The Niche Stem Cell & Regen Med Website

We have a new post today!

FDA news: warning letter pattern, cancer moonshot, CAR-T & gene-editing guidance

The FDA has been busy with the COVID pandemic but it has many other things on its plate as well including cell therapies. Today I'm sharing some recent agency news and brief perspectives on it. FDA focus on clinic-related umbilical cord cell drug makers The agency warned an Idaho company that produces and sells umbilical cord cells. The firm, Smart …
FDA-draft-guidance